Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone added to lidocaine for infraclavicular block in upper limb fracture surgery
IRCT20220120053774N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone and lidocaine in upper extremity fracture (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Onset of analgesia, Onset of immobility and 2 more. Started Mar 2022; status: completed.
02
Drugs
dexamethasonelidocaine
03
Conditions
upper extremity fracture
Beyond the preview
Go deeper on IRCT20220120053774N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220120053774N1.